I now have comprehensive content from multiple authoritative textbooks with excellent diagrams. Let me compile the full detailed answer.
Pathogenesis of Helicobacter pylori Infection
False-colored scanning electron micrograph showing H. pylori (red) on gastric epithelial cells. - Yamada's Textbook of Gastroenterology, 7th ed.
1. The Organism
H. pylori is a gram-negative, spiral-shaped bacillus (~3.5 µm long, 0.5 µm wide). Its helical shape enables it to corkscrew through the thick gastric mucus layer. It is microaerophilic, urease-positive, and lives exclusively on gastric-type mucosa, deep in the mucus layer overlying the epithelium. - Yamada's Textbook of Gastroenterology, 7th ed.
2. Colonization and Survival in the Gastric Niche
Before causing disease, the organism must overcome the hostile environment of the stomach:
| Mechanism | How it works |
|---|
| Urease | Hydrolyzes urea → NH₃ + CO₂; ammonia buffers local acidity, maintaining periplasmic pH near neutral even in acid |
| Flagella | Corkscrew motility allows movement through viscous mucus; bacteria also sense pH and actively migrate away from acidic microenvironments toward the epithelial surface |
| Adhesins (outer membrane proteins) | BabA binds fucosylated Lewis-b (Le^b) antigen on epithelial cells; SabA binds sialyl-Lewis^x; HopQ binds CEACAM family molecules - anchoring the organism to the gastric epithelium and preventing clearance by peristalsis |
| Mucin degradation | H. pylori decreases mucin synthesis, helping it penetrate the mucous layer |
- Robbins, Cotran & Kumar Pathologic Basis of Disease; Yamada's Textbook of Gastroenterology, 7th ed.
3. Key Virulence Factors
A. CagA (Cytotoxin-Associated Gene A) - the "oncoprotein"
- Encoded within the cag pathogenicity island (cag PAI), a ~40-kb genomic segment
- CagA is injected directly into gastric epithelial cells via a type IV secretion system (T4SS) - essentially a molecular syringe
- Once inside host cells, CagA is tyrosine-phosphorylated by Src and Abl kinases, and activates multiple growth factor signaling pathways (Ras-ERK, PI3K, SHP-2)
- This stimulates abnormal cell proliferation, disrupts tight junctions, and contributes to the carcinogenic cascade
- CagA-positive strains cause more severe inflammation and are strongly associated with gastric adenocarcinoma and duodenal ulcer
- The cag T4SS also translocates heptose bisphosphate (HBP), a metabolite that activates NF-κB via TIFA, amplifying inflammatory cytokine production (IL-8, TNF-α, IL-1β)
- H. pylori DNA itself is translocated into host cells via T4SS, activating intracellular TLR9
B. VacA (Vacuolating Cytotoxin A)
- A secreted pore-forming toxin present in virtually all H. pylori strains, but with major functional variation based on allele type
- The vacA gene has polymorphic regions: the signal (s) region (s1 or s2) and the middle (m) region (m1 or m2)
- vacA s1/m1 strains induce strongest vacuolation and are most strongly linked to ulcer disease and gastric cancer
- s2/m2 strains show no vacuolating activity
- VacA effects on host cells:
- Induces large cytoplasmic vacuoles by disrupting endosomal/lysosomal trafficking
- Triggers apoptosis of epithelial cells
- Suppresses T-cell responses - contributing to the longevity of infection by impairing immune clearance
C. Other Virulence Factors
-
OipA (outer inflammatory protein A): induces IL-8 production
-
DupA: associated with duodenal ulcer risk
-
Lipopolysaccharide (LPS): weakly immunogenic compared to other gram-negatives; contains Lewis antigens (Le^x, Le^y) that mimic host antigens - a mechanism of molecular mimicry allowing immune evasion
-
Mulholland and Greenfield's Surgery, 7th ed.; Yamada's Textbook of Gastroenterology, 7th ed.; Sherris & Ryan's Medical Microbiology, 8th ed.
4. Host Inflammatory Response
All H. pylori infections are associated with histological gastritis - infiltration of lymphocytes and neutrophils into the gastric mucosa. The inflammatory cascade proceeds as follows:
- Bacterial adhesion and virulence factor injection trigger epithelial cells to secrete IL-8 and other chemokines
- Neutrophil and lymphocyte recruitment → mucosal infiltration
- Activated macrophages and T cells release TNF-α, IL-1β, IL-6, IL-12
- Reactive oxygen species (ROS) from neutrophils cause direct epithelial DNA damage
- Chronic inflammation drives polyclonal B-cell proliferation → can give rise to gastric MALToma if driver mutations are acquired
The pattern of gastritis (antral-predominant vs. pangastritis) is the key determinant of which disease the patient develops.
Pathogenesis of H. pylori gastritis. - Robbins, Cotran & Kumar Pathologic Basis of Disease
5. Disease Outcomes - Determined by Gastritis Pattern
H. pylori-induced duodenal ulceration pathway: antral inflammation → ↓ somatostatin → ↑ gastrin → ↑ acid → duodenal metaplasia → DU. - Yamada's Textbook of Gastroenterology, 7th ed.
A. Antral-Predominant Gastritis → Duodenal Ulcer (DU)
- H. pylori colonizes predominantly the antrum, leaving the acid-producing corpus relatively spared
- Antral inflammation suppresses somatostatin production by D cells
- Loss of somatostatin removes the normal negative feedback on G cells → hypergastrinemia
- Excess gastrin increases parietal cell mass and stimulates ECL cells → ↑ histamine → ↑ acid output from the healthy corpus
- The increased acid load in the duodenum promotes gastric metaplasia of the duodenal bulb (protective response to excess acid)
- H. pylori can only colonize gastric-type mucosa - gastric metaplasia now allows duodenal colonization → local inflammation and ulceration
- Bicarbonate secretion by the duodenum is also reduced, removing a key mucosal defense
B. Pangastritis → Gastric Ulcer (GU) and Gastric Adenocarcinoma
- Inflammation involving both antrum and corpus (pangastritis)
- Corpus inflammation damages parietal cells → normal or reduced acid (so DU does not develop)
- Progressive atrophy of parietal glands → hypochlorhydria → continued hypergastrinemia
- Reduced acid creates a permissive environment for further bacterial colonization and mucosal damage
- If inflammation is severe, particularly at transitional zones of mucosal weakness (lesser curvature junction of antral and oxyntic mucosa), gastric ulcers form
- Progressive atrophy → intestinal metaplasia → dysplasia → gastric adenocarcinoma (the Correa cascade)
This explains the inverse relationship between DU (associated with high acid/antral pattern) and gastric cancer (associated with atrophy/pangastritis pattern) - both are caused by H. pylori but are mutually somewhat exclusive.
6. Carcinogenesis - The Correa Cascade
H. pylori is a WHO Group I carcinogen (definite human carcinogen). The proposed sequence for intestinal-type gastric adenocarcinoma is:
Normal mucosa → Chronic active gastritis → Atrophic gastritis → Intestinal metaplasia → Dysplasia → Adenocarcinoma
Key contributing factors:
-
CagA activates growth factor signaling (SHP-2, Ras-ERK, PI3K) mimicking sustained growth factor stimulation
-
Chronic inflammation produces mutagenic reactive oxygen/nitrogen species causing DNA strand breaks
-
Hypochlorhydria allows overgrowth of other bacteria that produce carcinogenic N-nitroso compounds
-
Sustained hypergastrinemia is trophic for gastric epithelium
-
H. pylori also causes polyclonal B-cell proliferation that can acquire driver mutations → gastric B-cell MALToma (MALT lymphoma) (eradication of H. pylori can cause MALToma regression)
-
Robbins, Cotran & Kumar Pathologic Basis of Disease; Yamada's Textbook of Gastroenterology, 7th ed.
7. Host Genetic Factors Modifying Disease
Not everyone with the same virulent strain develops the same disease. Host polymorphisms are key:
- IL-1β gene polymorphisms (particularly IL-1β -511 and +31): IL-1β is both a pro-inflammatory cytokine and a potent acid-suppressant. Polymorphisms causing ↑ IL-1β production → more atrophy/cancer risk rather than ulcer
- IL-1RA, TNF-α, IL-10 polymorphisms: modify mucosal inflammatory intensity
- Blood group O: increases H. pylori adhesion (H. pylori expresses adhesins that bind blood group antigens) → higher risk of PUD; blood groups A/B/AB have relative risk 0.75-0.91
- HLA-DQA1 genotype: associated with H. pylori-negative ulcer disease
Summary Table
| Feature | Antral gastritis | Pangastritis |
|---|
| Acid secretion | Increased | Normal/decreased |
| Gastrin | Elevated | Elevated |
| Somatostatin | Decreased | Decreased |
| Outcome | Duodenal ulcer | Gastric ulcer / adenocarcinoma |
| CagA role | Major (ulcer risk) | Major (cancer risk) |
Sources: